MJFF awards grant to study skin test that detects alpha-synuclein...
CND Life Sciences won $4.2 million from The Michael J. Fox Foundation for Parkinson's Research to study a skin test in Parkinson’s disease.
25 Nov 13:00 · Parkinson's News Today
Phase 2 trial of therapy for LRRK2-tied Parkinson's may open soon
The study, possibly to open in January, will test oral NEU-411 against a placebo in early-stage patients with specific LRRK2 markers
25 Nov 13:00 · Parkinson's News Today
last updated on 25 Nov 17:40